Skip to main content
HHS Logo U.S. Department of Health & Human Services Divider arrow NIH logo National Institutes of Health Alt desc
grdr boy on swing

New Funding Opportunities Available for Rare Diseases Research

NCATS has released two new funding opportunities to support research on rare diseases through the Rare Diseases Clinical Research Network.

Human eosinophils releasing inflammatory proteins.

Team Identifies Three Distinct Forms of Rare Food Allergy Disease

With support from the Rare Diseases Clinical Research Network, scientists have developed a personalized approach to diagnosing and treating eosinophilic esophagitis.


Potential Gene-Editing Treatment Advances to Clinical Trials

RDCRN-supported researchers charted how several rare diseases progressed in patients over time, helping to enable a potential gene-editing therapy to advance to clinical trials.

Rare Diseases Clinical Research Network (RDCRN)

The RDCRN program is designed to advance medical research on rare diseases by providing support for clinical studies and facilitating collaboration, study enrollment and data sharing. Through the RDCRN consortia, physician scientists and their multidisciplinary teams work together with patient advocacy groups to study more than 200 rare diseases at sites across the nation.

Find NCATS Programs & InitiativesAccess NCATS Expertise & Resources

About the RDCRN

Learn more about the RDCRN program and its network of study sites.

RDCRN Funding Information

Find out about funding opportunities, how to apply and how to collaborate.

Current RDCRN Consortia

Discover the 22 consortia and their central data management and coordinating center.

Rare Diseases Health Information

Access information about rare diseases for patients and researchers.

Genetic and Rare Diseases Information Center (GARD)

GARD provides up-to-date health information about numerous rare and genetic diseases.

RDCRN Overview

The RDCRN program is designed to advance medical research on rare diseases. It facilitates clinical research in rare diseases through support for:

  • Collaborative activities, including multisite longitudinal studies of individuals with rare diseases, and/or clinical trials
  • Training of clinical investigators in rare diseases research
  • Pilot and demonstration projects
  • Uniform data collection protocols
  • Access to information about rare diseases for basic and clinical researchers, academic and practicing physicians, patients, and the public

Learn more about the RDCRN program and its goals.